Kura Oncology

Kura Oncology

Biotechnology
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company’s pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

$731.3M

Market Cap • 9/3/2025

2007

(18 years)

Founded

2015

(10 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country